TipRanks
ArborGen Holdings Limited (NZ:ARB)
:ARB
Want to see NZ:ARB full AI Analyst Report?

ArborGen Holdings (ARB) AI Stock Analysis

1 Followers

Top Page

NZ:ARB

ArborGen Holdings

(ARB)

Select Model
Select Model
Select Model
Neutral 47 (OpenAI - Gpt-5.6Sol)
Rating:47Neutral
Price Target:
$0.07
▲(15.00% Upside)
Action:N/A
Date:10/05/26
The score is held back primarily by weak financial performance—continued net losses, a FY2026 revenue decline, and negative/volatile free cash flow—despite a relatively manageable balance sheet. Technicals are moderately supportive in the short term (neutral RSI and slightly positive MACD), but longer-term trend signals remain weaker. Valuation is penalized due to negative earnings (negative P/E) and no available dividend yield data.
Positive Factors
Advanced genetics and higher-value seedlings
ArborGen’s advanced genetics offering and move toward higher-value seedlings support a differentiated business model focused on productivity and quality. If execution continues, these products may help preserve pricing power, improve margins, and strengthen customer value over the next several quarters.
Negative Factors
Revenue contraction and persistent net losses
The recent revenue decline reverses earlier growth and shows that ArborGen has not yet established dependable demand across its operations. Continued net losses weaken retained capital and make it harder for operating improvements to translate into sustainable shareholder returns.
Read all positive and negative factors
Positive Factors
Negative Factors
Advanced genetics and higher-value seedlings
ArborGen’s advanced genetics offering and move toward higher-value seedlings support a differentiated business model focused on productivity and quality. If execution continues, these products may help preserve pricing power, improve margins, and strengthen customer value over the next several quarters.
Read all positive factors

ArborGen Holdings (ARB) vs. SPDR S&P 500 ETF (SPY)

ArborGen Holdings Business Overview & Revenue Model

Company Description
ArborGen Holdings Limited specializes in the field of forestry genetics, providing tree seedlings marketed under the ArborGen brand. The company primarily serves the forestry industries within the United States and Brazil. Established in 2001, thi...

ArborGen Holdings Financial Statement Overview

Summary
Financials are mixed and volatile: FY2026 revenue fell (-15.6%) and the company still reported a sizable net loss despite a recovery in operating profit and solid EBITDA margin (~17%). The balance sheet is reasonably positioned with moderate leverage (debt-to-equity ~0.35), but negative ROE (~-6%) signals weak efficiency. Cash flow is the biggest concern with negative free cash flow (~-$4.1M) and weak cash conversion.
Income Statement
44
Neutral
Balance Sheet
63
Positive
Cash Flow
38
Negative
BreakdownMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue116.17M110.74M112.98M89.29M68.45M
Gross Profit21.63M31.89M40.05M28.97M25.60M
EBITDA20.27M-7.89M13.18M20.07M12.65M
Net Income-12.77M-37.67M-328.16K-3.98M2.44M
Balance Sheet
Total Assets305.72M307.52M329.85M318.00M276.24M
Cash, Cash Equivalents and Short-Term Investments3.86M6.13M9.35M20.21M21.86M
Total Debt71.87M57.12M44.64M48.70M45.59M
Total Liabilities97.47M89.19M81.25M80.38M58.53M
Stockholders Equity208.26M218.33M248.60M237.63M217.72M
Cash Flow
Free Cash Flow-4.09M-8.94M6.07M-563.08K1.71M
Operating Cash Flow2.90M4.73M16.90M8.35M8.33M
Investing Cash Flow-6.13M-5.96M-10.35M-8.75M15.24M
Financing Cash Flow511.00K-1.58M-21.03M-5.57M-13.66M

ArborGen Holdings Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.06
Price Trends
50DMA
0.07
Negative
100DMA
0.07
Negative
200DMA
0.09
Negative
Market Momentum
MACD
<0.01
Positive
RSI
45.88
Neutral
STOCH
27.78
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NZ:ARB, the sentiment is Negative. The current price of 0.06 is below the 20-day moving average (MA) of 0.07, below the 50-day MA of 0.07, and below the 200-day MA of 0.09, indicating a bearish trend. The MACD of <0.01 indicates Positive momentum. The RSI at 45.88 is Neutral, neither overbought nor oversold. The STOCH value of 27.78 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for NZ:ARB.

ArborGen Holdings Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
54
Neutral
$3.65B16.215.98%7.72%-14.30%―
47
Neutral
$34.47M-2.60-6.07%―8.17%65.34%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
NZ:ARB
ArborGen Holdings
0.07
-0.06
-47.20%
NZ:FBU
Fletcher Building Limited
3.39
-0.09
-2.59%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 05, 2026